Cell-Easy

Toulouse, France

Cell-Easy is a CDMO that specializes in preclinical and clinical drug development.

$8.7M raised

Feb 2022

Undisclosed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cell-Easy raised?

Cell-Easy has raised $8.7M in total funding. The most recent round was Undisclosed. The last funding was announced in February 2022.

Who are Cell-Easy's investors?

Cell-Easy's investors include Bpifrance.

Where is Cell-Easy headquartered?

Cell-Easy is headquartered in Toulouse, France.

What does Cell-Easy do?

Cell-Easy is a CDMO that specializes in preclinical and clinical drug development.

What stage is Cell-Easy at?

Cell-Easy is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 28, 2022.

MLA

"Cell-Easy — Funding & Investors." VCBacked, February 28, 2022, https://www.vcbacked.co/company/cell-easy. Accessed July 2, 2026.

APA

VCBacked. (2022). Cell-Easy — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cell-easy

Wikipedia (cite web)

{{cite web |title=Cell-Easy — Funding & Investors |url=https://www.vcbacked.co/company/cell-easy |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 28, 2022.